People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

Here are some practical guidelines and considerations for safely exercising while on GLP-1 medications. Text Callout : Key Takeaways - Exercising on GLP-1s How GLP-1 Medications Affect the Body ...

Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...

When her consultant offered 20st Sarah a brand new injection called Ozempic that promised to treat her diabetes and help her ...

Eli Lilly's performance in the biopharmaceutical sector reflects its strong market position, despite facing challenges. The ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

Ozempic, Wegovy, Mounjaro, and Saxenda – from Hollywood to high street pharmacies, they are everywhere. These are the weight loss drugs that have been hailed as a “ miracle ” and the “ wonder drug [s] ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

FACE-TO-FACE appointments should be mandatory ahead of approving fat jab prescriptions, leading pharmacists say. The ...